We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Upper Tribunal Administrative Appeals Chamber decision by Judge Stout on 22 June 2026.
AMRHAI (Antimicrobial Resistance and Healthcare Associated Infections) is the national reference unit for investigating antimicrobial resistance in healthcare-associated bacteria.
Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.
Information for British people on medical support in Thailand including mental health, lists of hospitals and care homes and how the British embassy can help.
How to use a case-control study to evaluate your digital health product.
UKHSA identifies infection risks, evaluates intervention impact, and generates insights that guide national policy.
UKHSA advances infection prevention and antimicrobial stewardship through integrated research, specialist microbiology, community interventions and large‑scale studies.
The management, surveillance and epidemiology of carbapenem resistance.
Mandatory surveillance of healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Klebsiella species (Klebsiella. spp.), and Clostridioides difficile (C. difficile) infection. Annual data and epidemiological commentary for the financial year April...
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).